More patients will soon be getting Zostavax to prevent shingles

December 2006

More patients will soon be getting Zostavax to prevent shingles. It's for patients age 60 and over. About 50 million will be eligible.

This new vaccine reduces the risk of shingles by about 50%... and reduces postherpetic neuralgia by 67%.

And there are no significant side effects for most people.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote